TCL Archive Von Eschenbach takes leave of absence from NCI, resigns from C-Change board. Acting FDA commissioner’s drug approval strategy rooted in unproven science. Von Eschenbach told NCI deputies he might drop in on meetings. Who’s really in charge? October 7, 2005
TCL Archive In Brief: Brinkley Asks Subcommittee to Add $62.5 Million To NCI Budget for Unfunded Grants May 11, 1979
TCL Archive In Brief: David Johnson New ACCC President, William Dugan Named President Elect; Straus Resigns From NYMC March 12, 1982
